Skip to main content
Equibles
GRDN logo

GRDN · Guardian Pharmacy Services, Inc.

Track GRDN — free

Use GRDN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about GRDN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$38.43 -0.03 (-0.08%) At close · Aug 14
Market Cap
$2.43B
Shares
63.34M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$38.43 Open$38.37 Day$37.58–39.05 52W close$23.41–43.83 Avg vol 30d341K Short int2.9M · 4.5% float · 9.6d Short vol39% Last earningsAug 6, 2026 DataSep 2024–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +9%
      above
      Price vs 50-day avg −6%
      below
      RSI (14) 43
      neutral
      MACD trend Negative
      52-week position 74%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return −5%
      trailing
      6-month return +16%
      trailing
      YTD return +28%
      this year
      Relative strength +3%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $41 › 200d $35 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +34 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.50% of float · ▲ +2.2% MoM · 9.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      185 holders — near 2-yr high, broad support
      Squeeze score 54
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +18%
      Y/Y
      Gross margin 20%
      expanding
      Balance sheet $46.6M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 42%
      annualized · 1-yr
      Max drawdown −23%
      past year
      ATR 5.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Revenue · FY 2026 $1.43B – $1.45B
      Adjusted EBITDA · FY 2026 Non-GAAP $129M – $131M
      Prior guidance period ended · from the 8-K filed Jan 13, 2026
      Adjusted EBITDA · 2025 Guidance $104M – $106M
      Adjusted EBITDA Margin · 2025 Guidance 7.4%
      Guided vs delivered · last 1 settled
      Revenue FY 2025
      guided $1.43B – $1.45B
      $1.45B In line

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +9% Bullish
      Price vs 50-day avg
      −6% Bearish
      RSI (14)
      43 Neutral
      MACD trend
      Negative Bearish
      52-week position
      74% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $41 › 200d $35 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +34 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.50% of float · ▲ +2.2% MoM · 9.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      185 holders — near 2-yr high, broad support
      Price context
      position in its 52-week range
      Range low $23 Now $38 · 74% Range high $44
      vs 200-day avg +9% vs 50-day avg -6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Full-service pharmacies 54 as of June 30, 2026 —
      Total pharmacies 61 Full Year 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      GRDN
      Guardian Pharmacy Services, Inc.
      this stock
      		$2.43B +27.7% +17.9% — 4.5%
      HCA
      HCA Healthcare, Inc.
      		 $89.77B -13.3% +7.1% 13.9 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      		 $30.87B -4.4% — — 0.0%
      THC
      Tenet Healthcare Corp
      		 $21.57B +34.8% +0.9% 10.3 4.0%
      FMS
      Fresenius Medical Care AG
      		 $12.65B -0.2% +5.9% — 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      185
      % held
      46.3%
      Net QoQ
      +976.7K sh
      Top holder
      FMR LLC
      Held Float
      View
      Held by Funds
      Fund positions
      219
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      2.9M
      Days to cover
      9.6d
      Change
      +61.3K sh
      View
      Short Volume
      Short vol %
      39%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      8
      Value
      $335
      As of
      Jul 1, 2026
      View
      Off-Exchange
      Off-exchange %
      46.1%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $1.4B
      Net income (FY)
      $49.2M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      12
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      Guardian Pharmacy Services Report…
      Published
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      GRDN -12.3% -5.2% +16.4% -2.8% +27.7%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -12.7% -9.6% +2.7% -6.7% +13.9%
      Key facts CIK 1802255 CUSIP 40145W101 13F (30d) 178 filings 178 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)